Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Enterprise Value (2021 - 2026)

Adagene (ADAG) posted quarterly Enterprise Value of -$75.8 million for Q4 2025, up 12.8% year-over-year from -$67.2 million in Q4 2024, and down 17.78% quarter-over-quarter from -$64.4 million in Q2 2025.

Analysis

Adagene (ADAG) Enterprise Value (2021 - 2026) Analysis & Trends

Adagene (ADAG) has reported Enterprise Value for 7 consecutive years, with -$75.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Enterprise Value rose 12.8% year-over-year to -$75.8 million; the TTM figure through Dec 2025 stood at -$75.8 million (up 12.8% YoY), while the FY2025 annual figure was -$75.8 million, up 12.8% from the prior year.
  • Enterprise Value eased to -$75.8 million in Q4 2025 per ADAG's latest filing, from -$64.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$128.76 in Q2 2023 and bottomed at -$208.3 million in Q2 2021.
  • Historically, Enterprise Value has averaged -$96.8 million across 5 years, with a median of -$92.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Enterprise Value soared 100.0% — and 2024, when it sank 75757500.02%.
  • Adagene's Enterprise Value stood at -$176.3 million in 2021, then grew by 16.76% to -$146.7 million in 2022, then grew by 23.86% to -$111.7 million in 2023, then grew by 22.15% to -$87.0 million in 2024, then rose by 12.8% to -$75.8 million in 2025.
  • Business Quant data shows ADAG's Enterprise Value at -$75.8 million in Q4 2025, -$64.4 million in Q2 2025, and -$87.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.70 Mn
Dec 31, 2025 36.10 Mn
Jun 30, 2025 50.43 Mn
Dec 31, 2024 30.21 Mn
Jun 30, 2024 71.20 Mn
Dec 31, 2023 -5.29 Mn
Jun 30, 2023 -48.74 Mn
Dec 31, 2022 -74.82 Mn
Jun 30, 2022 -55.02 Mn
Dec 31, 2021 264.32 Mn
Jun 30, 2021 16.86 Mn